The new WHO classification for acute myeloid leukemias and myelodysplastic syndromes:: Is it better than the FAB system?

被引：0
|
作者：
Löffler, H [1 ]
Haferlach, T [1 ]
机构：
[1] Univ Munich, Grosshaden, Med Klin & Poliklin 3, Munich, Germany
来源：
MEDIZINISCHE WELT | 2000年 / 51卷 / 11期
关键词：
acute myeloid leukemia; prognosis; cytomorphology; cytogenetic; WHO-classification;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Since 25 years the FAB (French-American-British) classification was used for acute myeloid leukemias (AML) and myelodysplastic syndromes (MDS). Now the WHO published a new proposal that is primary hosed on cytogenetic and molecular markers. In parallel, the history of the AML evolving from on MDS or therapy-related is taken into account. Dysplastic features ore also analyzed for further categories. The blast count for AML is newly defined to be more than 20%. This WHO proposal points out in the light direction. Its value for therapy, prognosis and its clinial relevance for a single patient has to be investigated prospectively.
引用
收藏
页码：329 / 331
页数：3
相关论文
共 50 条
  • [31] Increased Risk of Acute Myeloid Leukemias and Myelodysplastic Syndromes in Patients Who Received Thiopurine Treatment for Inflammatory Bowel Disease
    Lopez, Anthony
    Mounier, Morgane
    Bouvier, Anne-Marie
    Carrat, Fabrice
    Maynadie, Marc
    Beaugerie, Laurent
    Peyrin-Biroulet, Laurent
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2014, 12 (08) : 1324 - 1329
  • [32] THREE-DIMENSIONAL NUCLEAR TELOMERIC PROFILES IN MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIAS
    Gadji, Macoura
    Toure, Awa Oumar
    Ndiaye, Fatou Samba Diago
    Sall, Abibatou
    Seck, Moussa
    Faye, Blaise
    Diop, Saliou
    Dieye, Tandakha Ndiaye
    Mai, Sabine
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2013, 35 : 12 - 13
  • [33] A PROGNOSTIC SCORING MODEL FOR PATIENTS TREATED WITH AZACITIDINE FOR MYELODYSPLASTIC SYNDROMES/ACUTE MYELOID LEUKEMIAS
    Sato, K.
    Inamura, J.
    Tsukada, N.
    Sato, K.
    Hosoki, T.
    HAEMATOLOGICA, 2016, 101 : 503 - 503
  • [34] Analysis of immunohistochemical markers in bone marrows to evaluate for myelodysplastic syndromes and acute myeloid leukemias
    Dunphy, CH
    O'Malley, DP
    LABORATORY INVESTIGATION, 2005, 85 : 228A - 228A
  • [35] Survivin expression in acute leukemias and myelodysplastic syndromes
    Invernizzi, R
    Travaglino, E
    Lunghi, M
    Klersy, C
    Bernasconi, P
    Cazzola, M
    Ascari, E
    LEUKEMIA & LYMPHOMA, 2004, 45 (11) : 2229 - 2237
  • [36] Expression of leptin receptors in mononuclear cells from myelodysplastic syndromes and acute myeloid leukemias
    Tsiotra, PC
    Pappa, V
    Koukourava, A
    Economopoulos, T
    Tsigos, C
    Raptis, SA
    ACTA HAEMATOLOGICA, 2005, 114 (02) : 71 - 77
  • [37] Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
    Aguayo, A
    Kantarjian, H
    Manshouri, T
    Gidel, C
    Estey, E
    Thomas, D
    Koller, C
    Estrov, Z
    O'Brien, S
    Keating, M
    Freireich, E
    Albitar, M
    BLOOD, 2000, 96 (06) : 2240 - 2245
  • [38] Analysis of immunohistochemical markers in bone marrows to evaluate for myelodysplastic syndromes and acute myeloid leukemias
    Dunphy, CH
    O'Malley, DP
    MODERN PATHOLOGY, 2005, 18 : 228A - 228A
  • [39] THE 5Q-ANOMALY IN 23 PATIENTS WITH MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIAS
    SUCIU, S
    WEH, HJ
    KUSE, R
    CALAVREZOS, A
    HOSSFELD, DK
    BLUT, 1987, 55 (04): : 406 - 406
  • [40] The transcription factor C/EBPα is mutated in myelodysplastic syndromes and acute myeloid leukemias.
    Gombart, AF
    Hofmann, WK
    Kawano, S
    Takeuchi, S
    Krug, U
    Kwok, SH
    Larson, R
    Asou, H
    Miller, CW
    Hoelzer, DF
    Koeffler, HP
    BLOOD, 2001, 98 (11) : 95A - 95A
12345